Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

December 31, 2025

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

News Daily News

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

September 30, 2025

LAAO During Cardiac Surgery May Help, Even in AF’s Absence

News Daily News

LAAO During Cardiac Surgery May Help, Even in AF’s Absence

September 17, 2024

Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea

News Daily News

Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea

August 27, 2024

Watchman FLX Gets DAPT Option Added to Label

News Daily News

Watchman FLX Gets DAPT Option Added to Label

September 06, 2022

News Industry News

BIOMODEX Technology Enables New Milestone in Interventional Cardiology

July 21, 2021

News Industry News

Conformal Medical's CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference

October 15, 2020

News Industry News

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

May 22, 2019

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

July 20, 2018

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

News Conference News ESC 2017

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

September 04, 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

News Industry News

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

October 03, 2016

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Industry News

Good Samaritan Hospital Offers an Alternative to Long-Term Warfarin Medication for Atrial Fibrillation with Newly Approved Watchman™ LAAC Implant

May 18, 2015

News Industry News

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

March 24, 2015

News Industry News

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

October 08, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.